RiverPark Ventures news & features
Lumen, a health tech company that analyses people’s metabolism based on the CO2 and
oxygen
in
their breath, has raised US$62m in Series B funding. The round was led by Pitango Venture
Capital,
with participating investors including, Hanwha Group, Resolute Ventures, RiverPark Ventures,
Unorthodox Ventures, Almeda Capital and Disruptive VC.
news •
05 Dec 2022
< First
1
Last >
TANITA is the founder of Bioelectrical Impedance Analysis (BIA) being the first to bring a ...
The focus for two decades was low temperature saltwater hydrotherapy, in particular the CryoSpa Sport ...